Efficacy of Ceftazidime and Cefepime in the Management of COVID-19 Patients: Single Center Report from Egypt
The purpose of this study was to explore the value of using cefepime and ceftazidime in treating patients with COVID-19. A total of 370 (162 males) patients, with RT-PCR-confirmed cases of COVID-19, were included in the study. Out of them, 260 patients were treated with cefepime or ceftazidime, with...
Saved in:
Main Authors: | Ragaey A. Eid (Author), Marwa O. Elgendy (Author), Ahmed O. El-Gendy (Author), Sara O. Elgendy (Author), Lassaad Belbahri (Author), Ahmed M. Sayed (Author), Mostafa E. Rateb (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Impact of Cefepime and Ampicillin/Sulbactam on Preventing Post-Cesarean Surgical Site Infections, Randomized Controlled Trail
by: Mona A. Abdelrahman, et al.
Published: (2023) -
Flavonoids as Potential anti-MRSA Agents through Modulation of PBP2a: A Computational and Experimental Study
by: Hani A. Alhadrami, et al.
Published: (2020) -
Demographic, clinical, and laboratory characteristics of patients with COVID-19 during the second and third waves of the pandemic in Egypt
by: Ragaey A. Eid, et al.
Published: (2021) -
Phytochemical and Biological Studies on the Different Organs of Tanacetum parthenium L. Cultivated in Egypt
by: MEM Rateb, et al.
Published: (2008) -
Barriers to Completing Therapy for Hepatitis C with Direct-Acting Antivirals: A Real-Life Experience from a Single Treatment Center in Egypt
by: Marwa M. Ahmed, et al.
Published: (2021)